Cite
HARVARD Citation
Patton, W. et al. (n.d.). An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia. Leukemia & lymphoma. 56 (10), pp. 2819-2825. [Online].